Heslin, Rothenberg, Farley & Mesiti P.C. is pleased to co-sponsor
The Science and Technology Law Center of Albany Law School’s panel program on scientific, legal and policy issues related to follow-on biologics. Continuing Legal Education credits will be offered.




  • Date: March 26, 2007


  • Time: 3:00 p.m. – 5:00 p.m. –  Reception to follow


  • Location: Albany Law School, 80 New Scotland Avenue, Albany, NY 12208-3494


About the Program:
More than 150 biologics have received regulatory approval and sales of medical biologics generate over $30 billion annually, a figure which is expected to double by 2010; however, a number of scientific, legal, and policy hurdles stand in the way of producing generic or follow-on versions of off-patent biologic products, effectively foreclosing the generic biologic market. Our panel will discuss these scientific, legal and policy issues, including:




  • Differences between biologics and small molecule drugs
  • Issues with FDA approval
  • Legislative update, including Sen. Waxman’s proposed bill -H.R. 6257
  • Effects on healthcare: cost and safety considerations
  • Options for the future of follow-on biologics